Epidemiology of hyperkalemia: an update.

Area of Science:

• Nephrology
• Internal Medicine
• Cardiology

Background:

• Hyperkalemia is a critical electrolyte disorder with life-threatening arrhythmia potential.
• It is infrequent in healthy individuals but common in those with predisposing conditions.
• Chronic kidney disease (CKD) patients are highly susceptible due to impaired potassium excretion and co-existing conditions.

Purpose of the Study:

• To highlight the significant risks associated with hyperkalemia.
• To emphasize the increased mortality and arrhythmia risk even at lower potassium levels.
• To identify key risk factors, including CKD and renin-angiotensin-aldosterone system inhibitors (RAASis).

Main Methods:

• Review of existing literature on hyperkalemia prevalence and outcomes.
• Analysis of risk factors contributing to hyperkalemia, focusing on CKD and medication use.
• Examination of the association between serum potassium levels and adverse events.

Main Results:

• Hyperkalemia is linked to increased all-cause mortality and malignant arrhythmias like ventricular fibrillation.
• Elevated mortality risk is evident even with serum potassium levels not typically targeted for intervention.
• Patients with CKD, diabetes mellitus, and those using RAASis face a heightened risk.

Conclusions:

• Hyperkalemia poses a substantial mortality risk across all patient populations.
• Proactive management is crucial, especially in vulnerable groups like CKD patients.
• Understanding risk factors like RAASi use is vital for preventing severe outcomes.